Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

The former president announced last year he has an aggressive form of prostate cancer. He and his aides say he’s doing well ...

While some of his allies have lamented that Biden's legacy as president has been reduced to questions of his declining health and mental acuity, many Democrats are still bitter about Biden's 2024 ...

Final overall survival data for PEACE-3 (NCT02194842) evaluating the combination of enzalutamide (Xtandi) and radium-223 ...

The thing that struck me hardest about prostate cancer wasn’t the diagnosis, it was the silence. Breast cancer, rightly, ...

GDF15 functions as a dual-edged regulator within the TME. On one hand, it suppresses anti-tumor immunity by impairing T cell recruitment and adhesion through inhibition of LFA-1/β2-integrin–mediated ...

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced that ...

With cancer cases rising sharply across India, the search for more precise, less invasive and patient-friendly treatments has ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Members of former President Joe Biden's inner circle are concerned that the 83-year-old Democrat is showing the strain of ...

The Radioligand Therapy Market is projected to reach US$13 billion by 2030, growing at an estimated rate of 5%. Key drivers of this growth include the rising incidence of cancers such as prostate ...